Reducing Supply Risk And CNS Neurology Trials

CNS and neurology trials present unique supply chain challenges that extend far beyond traditional clinical trial logistics. Complex titration schedules, individualized dosing adjustments, long study durations, and high dropout risk create operational demands that standard supply management approaches often struggle to support. A delayed shipment or missed visit can disrupt carefully managed dose escalation plans, potentially affecting patient retention and study continuity.

Modern RTSM strategies are evolving to address these realities by supporting dynamic dosing pathways, protocol-driven adjustments, blinded treatment management, and more accurate forecasting aligned with real-world patient journeys. Integrated approaches can also help study teams manage missed visits, rescheduling, adherence challenges, and drug accountability while maintaining flexibility across multi-year studies.

Learn how purpose-built trial supply technology can help sponsors navigate the complexity of CNS research, improve operational resilience, and support patient participation throughout the clinical trial lifecycle.